AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $246,000 | +58.7% | 53,225 | -3.4% | 0.00% | – |
| Q2 2020 | $155,000 | -13.9% | 55,125 | -25.3% | 0.00% | – |
| Q1 2020 | $180,000 | -70.8% | 73,825 | -38.7% | 0.00% | – |
| Q4 2019 | $617,000 | -22.5% | 120,425 | -2.3% | 0.00% | -100.0% |
| Q3 2019 | $796,000 | +2.8% | 123,287 | -0.8% | 0.00% | 0.0% |
| Q2 2019 | $774,000 | – | 124,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 875,000 | $4,043,000 | 2.05% |
| Opaleye Management Inc. | 2,039,100 | $9,421,000 | 1.84% |
| Consonance Capital Management LP | 3,236,335 | $14,952,000 | 1.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,152,998 | $5,327,000 | 0.52% |
| Blue Rock Advisors, LLC | 80,732 | $373,000 | 0.32% |
| DAFNA Capital Management LLC | 171,083 | $790,000 | 0.26% |
| Rubric Capital Management LP | 460,200 | $2,126,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 120,925 | $559,000 | 0.09% |
| Hudson Bay Capital Management LP | 1,325,000 | $6,122,000 | 0.09% |
| Ikarian Capital, LLC | 177,684 | $820,000 | 0.06% |